Literature DB >> 8690404

Transforming growth factor beta 1-regulated gene expression of Ito cells.

T Knittel1, T Janneck, L Müller, P Fellmer, G Ramadori.   

Abstract

During liver fibrogenesis, Ito cells are regarded as the principal matrix synthesizing cells and transforming growth factor beta 1 (TGF-beta 1) appears to be the main fibrogenic mediator. This study analyzed the effects of TGF-beta 1 on Ito cell activation, proliferation, and on the expression of a set of matrix proteins, antiproteases, and TGF-beta receptors both in "early cultured" and "culture-activated" Ito cells. Rat liver Ito cells at day 2 of primary culture ("early cultured" cells) were mainly smooth muscle alpha actin (SMA)-negative, whereas cells at day 6 were judged as "activated" cells (SMA-positive). Following 24-hour exposure to 1 ng/mL TGF-beta 1, total protein synthesis, cell proliferation, and expression of the "activation" marker SMA were not significantly changed. In addition to previously described stimulatory effects on collagen types I and III, fibronectin, undulin, and proteoglycan-gene expression, TGF-beta also dose-dependently increased synthesis and secretion of tenascin, laminin, entactin, collagen type IV, and alpha 2-macroglobulin, but decreased C1-esterase inhibitor production by Ito cells, as revealed by immunoprecipitation of endogenously labeled proteins and by Northern blot analysis. The stimulatory effect of TGF-beta was evident both in "early cultured" as well as "culture-activated" Ito cells. By reverse-transcription polymerase chain reaction (RT-PCR) analysis, TGF-beta type II, III, and TGF-beta/activin type I receptors were present in Ito cells, and their expression pattern was not changed upon TGF-beta exposure. Northern blot analysis demonstrated that type I TGF-beta/activin receptor was induced during in vitro activation and that TGF-beta exposure resulted in a slight increase of type I and III receptor messenger RNAs. In summary, the data illustrate that TGF-beta is an important fibrogenic mediator acting both on "early cultured" as well as "culture-activated" Ito cells, rather than a mitogenic or morphogenic mediator. The differential regulation of TGF-beta/activin receptors during in vitro activation and their up-regulation by TGF-beta 1 might represent a mechanism by which the receptor complex regulates TGF-beta signalling in Ito cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690404     DOI: 10.1053/jhep.1996.v24.pm0008690404

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

1.  Role of the Ets-1 transcription factor during activation of rat hepatic stellate cells in culture.

Authors:  T Knittel; D Kobold; J Dudas; B Saile; G Ramadori
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform.

Authors:  J George; S S Wang; A M Sevcsik; M Sanicola; R L Cate; V E Koteliansky; D M Bissell
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

3.  Effect of anti-fibrosis compound on collagen expression of hepatic cells in experimental liver fibrosis of rats.

Authors:  Ling-Tai Wang; Bin Zhang; Jian-Jie Chen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

4.  Sirtuin 3 (SIRT3) Regulates α-Smooth Muscle Actin (α-SMA) Production through the Succinate Dehydrogenase-G Protein-coupled Receptor 91 (GPR91) Pathway in Hepatic Stellate Cells.

Authors:  Ying Hui Li; Dae Hee Choi; Eun Hye Lee; Su Ryeon Seo; Seungkoo Lee; Eun-Hee Cho
Journal:  J Biol Chem       Date:  2016-02-24       Impact factor: 5.157

5.  Effect of transforming growth factor beta and bone morphogenetic proteins on rat hepatic stellate cell proliferation and trans-differentiation.

Authors:  Hong Shen; Guo-Jiang Huang; Yue-Wen Gong
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

6.  In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis.

Authors:  J George; D Roulot; V E Koteliansky; D M Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

7.  Co-administration of cyclosporine an alleviates thioacetamide-induced liver injury.

Authors:  Sabrina Fan; Ching-Feng Weng
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

8.  Succinate is a paracrine signal for liver damage.

Authors:  Paulo Renato A V Correa; Emma A Kruglov; Mayerson Thompson; M Fatima Leite; Jonathan A Dranoff; Michael H Nathanson
Journal:  J Hepatol       Date:  2007-04-05       Impact factor: 25.083

9.  Development of murine models to study Hepatitis C virus induced liver pathogenesis.

Authors:  Madiha Khalid; Sobia Manzoor; Muhammad Imran; Muqddas Tariq; Javed Ashraf; Qazi Laeeque Ahmed; Waseem Ashraf; Fahed Parvaiz; Muhammad Ashraf
Journal:  Indian J Virol       Date:  2013-09-14

10.  Expression of ECM proteins fibulin-1 and -2 in acute and chronic liver disease and in cultured rat liver cells.

Authors:  Fabio Piscaglia; József Dudás; Thomas Knittel; Paola Di Rocco; Dominik Kobold; Bernhard Saile; Maria Assunta Zocco; Rupert Timpl; Giuliano Ramadori
Journal:  Cell Tissue Res       Date:  2009-07-17       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.